Capital Group Launches Innovative Equity Solution with KKR
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy KKR?
Source: seekingalpha
- New Fund Launch: Capital Group announced on Tuesday the launch of an innovative equity solution in partnership with KKR, aimed at investing in KKR's funds and accounts to pursue private equity strategies, marking a deepening of collaboration in public-private credit strategies set for 2025.
- Asset Allocation Strategy: Approximately 60% of the Capital Group KKR U.S. Equity+ fund's assets will be invested in actively managed large-cap U.S. equities, enhancing portfolio diversity and providing investors with a more comprehensive way to engage in the evolution of the U.S. equity landscape.
- Liquidity and Accessibility Advantages: The fund is structured as an interval fund, offering periodic liquidity, no accreditation requirements, and lower minimums compared to standalone alternatives, thereby attracting a broader range of investors.
- Market Integration Philosophy: Holly Framsted, head of product group at Capital Group, stated that by integrating high-conviction public equity with private equity in one portfolio, investors can participate more fully in the evolution of the U.S. equity landscape, emphasizing the interconnectedness of public and private markets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KKR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KKR
Wall Street analysts forecast KKR stock price to rise
9 Analyst Rating
9 Buy
0 Hold
0 Sell
Strong Buy
Current: 90.610
Low
145.00
Averages
159.67
High
176.00
Current: 90.610
Low
145.00
Averages
159.67
High
176.00
About KKR
KKR & Co. Inc. is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions. The Company’s segments include Asset Management, Insurance and Strategic Holdings. Asset Management segment offers a range of investment management services to investment funds, vehicles and accounts and provides capital markets services to portfolio companies and third parties. Asset Management segment includes five business lines: Private Equity, Real Assets, Credit and Liquid Strategies, Capital Markets and Principal Activities. Insurance segment is operated by Global Atlantic, which is a United States retirement and life insurance company that provides a suite of protection, legacy and savings products and reinsurance solutions to clients across individual and institutional markets. Global Atlantic offers individuals fixed-rate annuities and others. Strategic Holdings segment represents its participation in its core private equity strategy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Capital Group Launches Innovative Equity Solution with KKR
- New Fund Launch: Capital Group announced on Tuesday the launch of an innovative equity solution in partnership with KKR, aimed at investing in KKR's funds and accounts to pursue private equity strategies, marking a deepening of collaboration in public-private credit strategies set for 2025.
- Asset Allocation Strategy: Approximately 60% of the Capital Group KKR U.S. Equity+ fund's assets will be invested in actively managed large-cap U.S. equities, enhancing portfolio diversity and providing investors with a more comprehensive way to engage in the evolution of the U.S. equity landscape.
- Liquidity and Accessibility Advantages: The fund is structured as an interval fund, offering periodic liquidity, no accreditation requirements, and lower minimums compared to standalone alternatives, thereby attracting a broader range of investors.
- Market Integration Philosophy: Holly Framsted, head of product group at Capital Group, stated that by integrating high-conviction public equity with private equity in one portfolio, investors can participate more fully in the evolution of the U.S. equity landscape, emphasizing the interconnectedness of public and private markets.
See More
Capital Group Launches First Public-Private Equity Strategy
- New Investment Strategy Launch: Capital Group has introduced its first public-private equity strategy, Capital Group KKR U.S. Equity+, which allocates approximately 60% of its assets to large-cap U.S. equities while incorporating private equity investments, aiming to broaden investment opportunities for retail investors.
- Expanded Market Access: The fund operates as an interval fund, offering periodic liquidity without accreditation requirements and lower minimum investments than typical private equity offerings, thereby enabling participation from a wider range of investors beyond ultra-high-net-worth individuals.
- Asset Management Scale: Capital Group manages over $3.4 trillion in assets, and the launch of this new strategy reflects the firm's belief in the synergistic management of public and private markets, asserting that their integration can create greater value.
- Educational Support Program: Alongside the product launch, Capital Group will provide financial advisor education, including portfolio construction tools and research to assist advisors in assessing liquidity, risk, and long-term fit within client portfolios.
See More
Blackstone Defends Quality of Private Credit Fund Amid Investor Withdrawals
- Investor Redemption Situation: In the last quarter, Blackstone's flagship private credit fund BCRED allowed investors to withdraw 7.9% of their capital, approximately $650 million, leading to an 8.5% drop in the company's stock price on Tuesday morning, indicating heightened market concerns about private credit.
- Loan Quality Defense: Blackstone President Jon Gray highlighted that over 400 borrowers in BCRED achieved 10% EBITDA growth last year, expressing optimism about loan quality despite the bearish market sentiment, which he believes will help stabilize investor confidence.
- Market Reaction Analysis: Although Blackstone's measures to allow investor redemptions aimed to address liquidity needs, this move did not alleviate market tensions but instead sparked broader concerns about the private credit sector, particularly regarding loans in the software industry.
- Fund Performance Data: BCRED has delivered an annualized return of 9.8% since inception for Class I shares, with a Blackstone spokesperson emphasizing the firm's commitment to meeting redemption requests, showcasing confidence in the fund and alignment with investors.
See More
Alternative Asset Managers Decline Following Withdrawals from Blackstone's Private Credit Fund
- Impact on Alternative Asset Managers: Some alternative asset managers are experiencing declines following issues with Blackstone's private credit fund.
- Withdrawal Concerns: The situation has been exacerbated by significant withdrawal requests from investors, raising concerns about liquidity and fund stability.
See More
Blackstone's BCRED Private Credit Fund Experiences Unprecedented Redemptions, Heightening Concerns.
- Blackstone's Private Credit Fund: The flagship private credit fund of Blackstone experienced significant redemptions in the first quarter, indicating challenges within the private credit sector.
- Impact on Stock Performance: Following the news of redemptions, Blackstone's stock saw a decline during early trading on Tuesday.
See More
Esperion Acquires Corstasis, Launches First FDA-Approved Nasal Diuretic
- Strategic Acquisition: Esperion is acquiring Corstasis for $75 million in cash, with Corstasis's Enbumyst™ being the first FDA-approved nasal diuretic, which is expected to significantly enhance Esperion's market position in cardiovascular care.
- Market Potential: Enbumyst targets 6.7 million American adults with heart failure, with a potential U.S. market opportunity exceeding $4 billion, addressing the growing medical needs and driving long-term revenue growth for Esperion.
- Innovative Treatment: Enbumyst offers self-administered outpatient diuretic therapy, bridging the gap between oral and IV treatments, which is expected to improve patient quality of life and reduce hospitalization rates.
- Future Outlook: Esperion plans to integrate Enbumyst into its existing commercial platform to drive sustained double-digit growth, further realizing its Vision 2040 and creating lasting value for patients and shareholders.
See More
Capital Group Launches Innovative Equity Solution with KKR
- New Fund Launch: Capital Group announced on Tuesday the launch of an innovative equity solution in partnership with KKR, aimed at investing in KKR's funds and accounts to pursue private equity strategies, marking a deepening of collaboration in public-private credit strategies set for 2025.
- Asset Allocation Strategy: Approximately 60% of the Capital Group KKR U.S. Equity+ fund's assets will be invested in actively managed large-cap U.S. equities, enhancing portfolio diversity and providing investors with a more comprehensive way to engage in the evolution of the U.S. equity landscape.
- Liquidity and Accessibility Advantages: The fund is structured as an interval fund, offering periodic liquidity, no accreditation requirements, and lower minimums compared to standalone alternatives, thereby attracting a broader range of investors.
- Market Integration Philosophy: Holly Framsted, head of product group at Capital Group, stated that by integrating high-conviction public equity with private equity in one portfolio, investors can participate more fully in the evolution of the U.S. equity landscape, emphasizing the interconnectedness of public and private markets.
See More
Capital Group Launches First Public-Private Equity Strategy
- New Investment Strategy Launch: Capital Group has introduced its first public-private equity strategy, Capital Group KKR U.S. Equity+, which allocates approximately 60% of its assets to large-cap U.S. equities while incorporating private equity investments, aiming to broaden investment opportunities for retail investors.
- Expanded Market Access: The fund operates as an interval fund, offering periodic liquidity without accreditation requirements and lower minimum investments than typical private equity offerings, thereby enabling participation from a wider range of investors beyond ultra-high-net-worth individuals.
- Asset Management Scale: Capital Group manages over $3.4 trillion in assets, and the launch of this new strategy reflects the firm's belief in the synergistic management of public and private markets, asserting that their integration can create greater value.
- Educational Support Program: Alongside the product launch, Capital Group will provide financial advisor education, including portfolio construction tools and research to assist advisors in assessing liquidity, risk, and long-term fit within client portfolios.
See More
Blackstone Defends Quality of Private Credit Fund Amid Investor Withdrawals
- Investor Redemption Situation: In the last quarter, Blackstone's flagship private credit fund BCRED allowed investors to withdraw 7.9% of their capital, approximately $650 million, leading to an 8.5% drop in the company's stock price on Tuesday morning, indicating heightened market concerns about private credit.
- Loan Quality Defense: Blackstone President Jon Gray highlighted that over 400 borrowers in BCRED achieved 10% EBITDA growth last year, expressing optimism about loan quality despite the bearish market sentiment, which he believes will help stabilize investor confidence.
- Market Reaction Analysis: Although Blackstone's measures to allow investor redemptions aimed to address liquidity needs, this move did not alleviate market tensions but instead sparked broader concerns about the private credit sector, particularly regarding loans in the software industry.
- Fund Performance Data: BCRED has delivered an annualized return of 9.8% since inception for Class I shares, with a Blackstone spokesperson emphasizing the firm's commitment to meeting redemption requests, showcasing confidence in the fund and alignment with investors.
See More
Alternative Asset Managers Decline Following Withdrawals from Blackstone's Private Credit Fund
- Impact on Alternative Asset Managers: Some alternative asset managers are experiencing declines following issues with Blackstone's private credit fund.
- Withdrawal Concerns: The situation has been exacerbated by significant withdrawal requests from investors, raising concerns about liquidity and fund stability.
See More
Blackstone's BCRED Private Credit Fund Experiences Unprecedented Redemptions, Heightening Concerns.
- Blackstone's Private Credit Fund: The flagship private credit fund of Blackstone experienced significant redemptions in the first quarter, indicating challenges within the private credit sector.
- Impact on Stock Performance: Following the news of redemptions, Blackstone's stock saw a decline during early trading on Tuesday.
See More
Esperion Acquires Corstasis, Launches First FDA-Approved Nasal Diuretic
- Strategic Acquisition: Esperion is acquiring Corstasis for $75 million in cash, with Corstasis's Enbumyst™ being the first FDA-approved nasal diuretic, which is expected to significantly enhance Esperion's market position in cardiovascular care.
- Market Potential: Enbumyst targets 6.7 million American adults with heart failure, with a potential U.S. market opportunity exceeding $4 billion, addressing the growing medical needs and driving long-term revenue growth for Esperion.
- Innovative Treatment: Enbumyst offers self-administered outpatient diuretic therapy, bridging the gap between oral and IV treatments, which is expected to improve patient quality of life and reduce hospitalization rates.
- Future Outlook: Esperion plans to integrate Enbumyst into its existing commercial platform to drive sustained double-digit growth, further realizing its Vision 2040 and creating lasting value for patients and shareholders.
See More
